A UK multicentre audit of the management of patients with primary hypercholesterolaemia or mixed dyslipidaemia with bempedoic acid against published lipid-lowering treatment targets

Background: Bempedoic acid, an adenosine triphosphate citrate lyase inhibitor, was introduced to UK practice via a pre-reimbursement access scheme for adults with primary hypercholesterolaemia or mixed dyslipidaemia who are at high risk of cardiovascular disease, in whom statins are either not toler...

Mô tả đầy đủ

Chi tiết về thư mục

Những tác giả chính:	Sudarshan Ramachandran, Amro Maarouf, Karen Mitchell, Tony Avades, Peter Smith, Lee Boulton, Jennifer Kelly, Nitasha Vekaria, Elizabeth Hughes
Định dạng:	Artigo
Ngôn ngữ:	Inglês
Được phát hành:	BioExcel Publishing Ltd 2024-08-01
Loạt:	Drugs in Context
Những chủ đề:	adenosine triphosphate bempedoic acid cholesterol hydroxymethylglutaryl coa reductases hypercholesterolaemia lipoprotein
Truy cập trực tuyến:	https://www.drugsincontext.com/a-uk-multicentre-audit-of-the-management-of-patients-with-primary-hypercholesterolaemia-or-mixed-dyslipidaemia-with-bempedoic-acid-against-published-lipid-lowering-treatment-targets/
Các nhãn:	Thêm thẻ Không có thẻ, Là người đầu tiên thẻ bản ghi này!